Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01138995 · ClinicalTrials.gov registry record · NA
Clinical Study of the L300 Versus Ankle-foot Orthosis (AFO) on Post-Stroke Subjects With Foot Drop
A NA study, sponsored by Bioness.
- Completed
- Registry status
- NA
- Development phase
- 197
- Enrollment target
NCT01138995 is a NA study that has completed, run by Bioness. The registered enrollment target is 197 participants.
The verdict
NCT01138995, a NA study, has completed, sponsored by Bioness.
- COMPLETED
- Registry status
- NA
- Development phase
- 197 participants
- Enrollment target
Study Summary
The objective of this study is to determine the effectiveness of the NESS L300 (L300) in improving gait parameters, function, and quality of life among stroke subjects (greater than or equal to 3 months post stroke)with drop foot.
Interventions
- DEVICE Ness L300
- DEVICE Ankle-foot orthosis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 197 participants |
| Start Date | 2010-05 |
| Est. Completion | 2013-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01138995
The ClinicalTrials.gov registry entry for NCT01138995 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 197 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bioness, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ness L300 is the first listed.
NCT01138995 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01138995 about?
NCT01138995 is a clinical study titled "Clinical Study of the L300 Versus Ankle-foot Orthosis (AFO) on Post-Stroke Subjects With Foot Drop". The objective of this study is to determine the effectiveness of the NESS L300 (L300) in improving gait parameters, function, and quality of life among stroke subjects (greater than or equal to 3 months post stroke)with drop foot.
What is the current status of trial NCT01138995?
This trial is currently completed. It is a NA study. The enrollment target is 197 participants. The study started on 2010-05. Estimated completion is 2013-02.
What interventions are being tested in trial NCT01138995?
The interventions under investigation include: Ness L300 (DEVICE), Ankle-foot orthosis (DEVICE).
Who is sponsoring clinical trial NCT01138995?
This trial is sponsored by Bioness, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.